A clinical study, using single-cell RNA sequencing of biopsy specimens from EGFR-mutant NSCLC, showed that macrophage infiltration decreased with EGFR-TKI treatment, to which the tumor was sensitive and increased in resistant cases. This evidence concerns the gene EGFR and non-small cell lung carcinoma.